Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Capricor Therapeutics Q3 EPS $(0.54) Beats $(0.55) Estimate

Author: Benzinga Newsdesk | November 10, 2025 04:04pm
Capricor Therapeutics (NASDAQ:CAPR) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.55) by 1.28 percent. This is a 42.11 percent decrease over losses of $(0.38) per share from the same period last year.

Posted In: CAPR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist